Grant of Options and PDMR dealing

Feedback plc

Grant of Options and PDMR dealing

Feedback plc (AIM: FDBK, "Feedback" or the "Company"), the clinical infrastructure specialist, announces that it has granted a total of 438,148 options to subscribe for new ordinary shares of 1 penny each in the Company ("Ordinary Shares") under the Company's EMI Share Option Scheme (the "Options") to Emma Oswick, Chief Financial Officer as detailed below.

The Options are being issued to appropriately incentivise management, as well as to ensure their interests are aligned with that of the Company and its Shareholders. The Options are exercisable at 20 pence per share. This price reflect the price at which the Company last completed an equity fundraise in November 2024 and represents a premium of 105% per cent to the closing share price on the last trading day before this announcement.

The Options will vest in four equal tranches as follows:

· 25% vest in three equal sub-tranches annually (8.33% on each of the first, second and third anniversary of grant of 22nd April 2026)

· 25% vest on reported revenue of £8m

· 25% vest on reported revenue of £12m; and

· 25% vest on reported revenue of £20m

"Reported Revenue" is either:

· a year's revenue reported in the full year audited financial statements; or

· 12 months' revenue being H2 of the last full year audited financial statements plus H1 of the last published interim financial statements.

The Options are exercisable for a period of 5 years from the vesting date.

Following the grant of Options, Emma Oswick will hold a total interest in the Company of 438,148 options. The Options represent in aggregate 1.0% of the Company's existing issued share capital.

Following the grant of the Options and taking into account existing options, the Company has a total of 4,481,061 options to subscribe for ordinary shares in the Company in issue, representing 10.2% of the Company's issued share capital at the date of this announcement.

Further information on Feedback and its products can be found on the Company's website: https://feedbackmedical.com

--Ends--

Enquiries:

About Feedback plc

Feedback plc is the strategic partner to unlock productivity in health and care through digital connectivity and asynchronous collaboration. With proven expertise in system integration, we enable teams to work flexibly, share information securely, and deliver care more efficiently.

Bleepa® is an award-winning collaboration platform that improves the quality and productivity of patient pathways enabling health and care organisations to hit targets with their existing clinical workforce. We achieve this by connecting digital infrastructure across systems, enabling asynchronous working, reducing geographic barriers and removing unnecessary appointments.

Bleepa supports the shift from analogue to digital and from hospital to community-based care, by uniting essential data and teams to enhance clinical decision making and enable better coordinated care.

The Company has a number of growth opportunities domestically and internationally across a range of public and private healthcare markets including the NHS. Our highly scalable software-as-a-service (SaaS) based model is expected to provide increasing levels of revenue visibility as the Company grows its customer base.

https://fbk.com

Notification and public disclosure of transactions by Persons Discharging Managerial Responsibilities under UK MAR